Fezolinetant (Veozah)

Fezolinetant is a non-hormonal medication FDA-approved for treating moderate to severe hot flashes in menopause. It works by blocking neurokinin 3 receptors in the brain's temperature regulation center. This page is for tracking only.

Track Fezolinetant (Veozah) adherence in the app

What people track

  • Medication timing and adherence consistency.
  • Hot flash frequency and severity before and after starting.
  • Side effect observations: abdominal pain, diarrhea, insomnia, back pain.
  • Liver function test dates as recommended by clinician.

Tracking tips

  • Establish a baseline by tracking hot flashes for 1-2 weeks before starting.
  • Log side effects with timestamps to identify patterns.
  • Compare weekly hot flash counts over time to see trends.
  • Set reminders for required monitoring appointments.

Clinician discussion prompts

  • How has your hot flash frequency changed since starting?
  • Are you experiencing any side effects?
  • Have you had required liver function monitoring?
  • How is your overall quality of life compared to before treatment?
Get the Stabilize app for Fezolinetant (Veozah) tracking

References